U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    CEBPB CCAAT enhancer binding protein beta [ Homo sapiens (human) ]

    Gene ID: 1051, updated on 23-Jul-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Dysregulation of TNF-induced protein 3 and CCAAT/enhancer-binding protein beta in alveolar macrophages: Implications for systemic sclerosis-associated interstitial lung disease.

    Dysregulation of TNF-induced protein 3 and CCAAT/enhancer-binding protein β in alveolar macrophages: Implications for systemic sclerosis-associated interstitial lung disease.
    Hua X, Hongbing R, Juan X, Jizan L, Beibei Y.

    05/13/2024
    rs822336 binding to C/EBPbeta and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC.

    rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC.
    Polcaro G, Liguori L, Manzo V, Chianese A, Donadio G, Caputo A, Scognamiglio G, Dell'Annunziata F, Langella M, Corbi G, Ottaiano A, Cascella M, Perri F, De Marco M, Col JD, Nassa G, Giurato G, Zeppa P, Filippelli A, Franci G, Piaz FD, Conti V, Pepe S, Sabbatino F., Free PMC Article

    04/5/2024
    MiR-155-5p improves the insulin sensitivity of trophoblasts by targeting CEBPB in gestational diabetes mellitus.

    MiR-155-5p improves the insulin sensitivity of trophoblasts by targeting CEBPB in gestational diabetes mellitus.
    Zhang H, Jiang Y, Zhu S, Wei L, Zhou X, Gao P, Zhang J, Chen Y, Du Y, Fang C, Su R, Li J, Wang S, Feng L.

    03/19/2024
    [C/EBPbeta mediates expressions of downstream inflammatory factors of the tumor necrosis factor-alpha signaling pathway in renal tubular epithelial cells with NPHP1 knockdown].

    [C/EBPβ mediates expressions of downstream inflammatory factors of the tumor necrosis factor-α signaling pathway in renal tubular epithelial cells with NPHP1 knockdown].
    Huang D, Liu Y, Li D, Zhang J, Yang Y, Sun L., Free PMC Article

    02/8/2024
    Transcriptional factor CCAAT enhancer binding protein beta inhibits epithelial-mesenchymal transition in cervical cancer via regulating attractin-like 1.

    Transcriptional factor CCAAT enhancer binding protein beta inhibits epithelial-mesenchymal transition in cervical cancer via regulating attractin-like 1.
    Fang M, Zhou Y, Li Z, Li X.

    01/4/2024
    Assessing the double-edged of extracellular signal-regulated kinase/CCAAT-enhancer-binding protein beta signaling pathway in arsenic-induced skin damage and its potential foodborne interventions.

    Assessing the double-edged of extracellular signal-regulated kinase/CCAAT-enhancer-binding protein beta signaling pathway in arsenic-induced skin damage and its potential foodborne interventions.
    Yang F, Hu D, Du S, Wu L, Gong M, Zhang Y, Yang X, Yang Y, Chen R, Xu Y, Zeng Q.

    11/22/2023
    Activation of BZW1 by CEBPB in macrophages promotes eIF2alpha phosphorylation-mediated metabolic reprogramming and endoplasmic reticulum stress in MRL/lpr lupus-prone mice.

    Activation of BZW1 by CEBPB in macrophages promotes eIF2α phosphorylation-mediated metabolic reprogramming and endoplasmic reticulum stress in MRL/lpr lupus-prone mice.
    Qi H, Zheng Z, Liu Q., Free PMC Article

    11/18/2023
    CRISPR screen identifies CEBPB as contributor to dyskeratosis congenita fibroblast senescence via augmented inflammatory gene response.

    CRISPR screen identifies CEBPB as contributor to dyskeratosis congenita fibroblast senescence via augmented inflammatory gene response.
    Westin ER, Khodadadi-Jamayran A, Pham LK, Tung ML, Goldman FD., Free PMC Article

    11/14/2023
    Inhibition of abnormal C/EBPbeta/alpha-Syn signaling pathway through activation of Nrf2 ameliorates Parkinson's disease-like pathology.

    Inhibition of abnormal C/EBPβ/α-Syn signaling pathway through activation of Nrf2 ameliorates Parkinson's disease-like pathology.
    Lin Z, Huang L, Cao Q, Luo H, Yao W, Zhang JC., Free PMC Article

    11/1/2023
    CEBPB regulates the migration, invasion and EMT of breast cancer cells by inhibiting THBS2 expression and O-fucosylation.

    CEBPB regulates the migration, invasion and EMT of breast cancer cells by inhibiting THBS2 expression and O-fucosylation.
    Qi L, Sun B, Yang B, Lu S.

    05/22/2023
    C/EBPbeta cooperates with MYB to maintain the oncogenic program of AML cells.

    C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells.
    Klempnauer KH., Free PMC Article

    03/20/2023
    CEBPB upregulates P4HA2 to promote the malignant biological behavior in IDH1 wildtype glioma.

    CEBPB upregulates P4HA2 to promote the malignant biological behavior in IDH1 wildtype glioma.
    Wang S, Wu J, Zhao W, Li M, Li S.

    03/16/2023
    C/EBPbeta Coupled with E2F2 Promoted the Proliferation of hESC-Derived Hepatocytes through Direct Binding to the Promoter Regions of Cell-Cycle-Related Genes.

    C/EBPβ Coupled with E2F2 Promoted the Proliferation of hESC-Derived Hepatocytes through Direct Binding to the Promoter Regions of Cell-Cycle-Related Genes.
    Liu S, Wang J, Chen S, Han Z, Wu H, Chen H, Duan Y., Free PMC Article

    02/16/2023
    C/EBPbeta expression decreases in cervical cancer and leads to tumorigenesis.

    C/EBPβ expression decreases in cervical cancer and leads to tumorigenesis.
    Long H, Li Y, Wang H, Guo B, Song S, Zhe X, Li H, Li D, Shao R, Pan Z., Free PMC Article

    02/4/2023
    C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC.

    C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC.
    Hartl L, Roelofs JJTH, Dijk F, Bijlsma MF, Duitman J, Spek CA., Free PMC Article

    01/28/2023
    C/EBPbeta Regulates TFAM Expression, Mitochondrial Function and Autophagy in Cellular Models of Parkinson's Disease.

    C/EBPβ Regulates TFAM Expression, Mitochondrial Function and Autophagy in Cellular Models of Parkinson's Disease.
    Sierra-Magro A, Bartolome F, Lozano-Muñoz D, Alarcón-Gil J, Gine E, Sanz-SanCristobal M, Alonso-Gil S, Cortes-Canteli M, Carro E, Pérez-Castillo A, Morales-García JA., Free PMC Article

    01/28/2023
    Analysis of DYRK1B, PPARG, and CEBPB Expression Patterns in Adipose-Derived Stem Cells from Patients Carrying DYRK1B R102C and Healthy Individuals During Adipogenesis.

    Analysis of DYRK1B, PPARG, and CEBPB Expression Patterns in Adipose-Derived Stem Cells from Patients Carrying DYRK1B R102C and Healthy Individuals During Adipogenesis.
    Armanmehr A, Jafari Khamirani H, Zoghi S, Dianatpour M.

    12/31/2022
    CEBPB regulates the bile acid receptor FXR to accelerate colon cancer progression by modulating aerobic glycolysis.

    CEBPB regulates the bile acid receptor FXR to accelerate colon cancer progression by modulating aerobic glycolysis.
    Wang Z, Pang J, Wang L, Dong Q, Jin D., Free PMC Article

    12/3/2022
    CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma.

    CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma.
    Yang J, Xu Y, Xie K, Gao L, Zhong W, Liu X., Free PMC Article

    11/19/2022
    Inhibition of CEBPB Attenuates Lupus Nephritis via Regulating Pim-1 Signaling.

    Inhibition of CEBPB Attenuates Lupus Nephritis via Regulating Pim-1 Signaling.
    Wang X, Cheng W, Chen X, Gong Y, Wang G, Zhang X, Qi Y., Free PMC Article

    10/22/2022
    CircZDBF2 up-regulates RNF145 by ceRNA model and recruits CEBPB to accelerate oral squamous cell carcinoma progression via NFkappaB signaling pathway.

    CircZDBF2 up-regulates RNF145 by ceRNA model and recruits CEBPB to accelerate oral squamous cell carcinoma progression via NFκB signaling pathway.
    Rong L, Chen B, Liu K, Liu B, He X, Liu J, Li J, He M, Zhu L, Liu K, Shi X, Shuai Y, Jin L., Free PMC Article

    07/16/2022
    CEBPB is required for NRF2-mediated drug resistance in NRF2-activated non-small cell lung cancer cells.

    CEBPB is required for NRF2-mediated drug resistance in NRF2-activated non-small cell lung cancer cells.
    Okazaki K, Anzawa H, Katsuoka F, Kinoshita K, Sekine H, Motohashi H.

    05/28/2022
    A synthetic covalent ligand of the C/EBPbeta transactivation domain inhibits acute myeloid leukemia cells.

    A synthetic covalent ligand of the C/EBPβ transactivation domain inhibits acute myeloid leukemia cells.
    Abdel Ghani L, Yusenko MV, Frank D, Moorthy R, Widen JC, Dörner W, Khandanpour C, Harki DA, Klempnauer KH.

    03/12/2022
    C/EBPbeta is a key transcription factor of ox-LDL inducing THP-1 cells to release multiple pro-inflammatory cytokines.

    C/EBPβ is a key transcription factor of ox-LDL inducing THP-1 cells to release multiple pro-inflammatory cytokines.
    Ma J, Yang X, Chen X.

    02/26/2022
    C/EBPbeta/AEP Signaling Regulates the Oxidative Stress in Malignant Cancers, Stimulating the Metastasis.

    C/EBPβ/AEP Signaling Regulates the Oxidative Stress in Malignant Cancers, Stimulating the Metastasis.
    Lei K, Kang SS, Ahn EH, Chen C, Liao J, Liu X, Li H, Edgington-Mitchell LE, Jin L, Ye K.

    02/12/2022
    firstprevious page of 14 nextlast